Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127215291 | 12721529 | 1 | I | 20160901 | 20160907 | 20160907 | PER | US-PFIZER INC-2016414870 | PFIZER | 33.00 | YR | F | Y | 56.00000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127215291 | 12721529 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | Y | 20699 | 75 | MG | QD | ||||||
127215291 | 12721529 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 20699 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127215291 | 12721529 | 1 | Depression |
127215291 | 12721529 | 2 | Anxiety |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127215291 | 12721529 | Gait disturbance | |
127215291 | 12721529 | Insomnia | |
127215291 | 12721529 | Muscle tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |